Estraflex® CMO (Cetylated Fatty Acids)

Evidence Level
Moderate
1 Clinical Trial
3 Documented Benefits
3/5 Evidence Score

Estraflex® CMO supplies cetylated fatty acids, a group of fats including cetyl myristoleate (CMO) studied for joint health. These specialized fatty acids appear to lubricate and calm the joints, and clinical research has examined them for improving comfort and function in osteoarthritis.

Studied Dose Commonly around 350 to 500 mg of cetylated fatty acids per day.
Active Compound Cetylated fatty acids, including cetyl myristoleate (CMO) and related cetylated esters.

Benefits

Joint function

In a randomized controlled trial, cetylated fatty acids improved knee function in people with osteoarthritis, supporting their joint-comfort positioning.

Joint comfort and mobility

Cetylated fatty acids are studied for easing joint stiffness and improving range of motion and everyday movement.

Joint lubrication

The fatty acids are thought to support the lubricating quality of joint tissue and fluid.

Mechanism of action

1

Membrane and lubrication support

Cetylated fatty acids incorporate into cell membranes and joint tissue, where they are thought to improve lubrication and reduce friction.

2

Anti-inflammatory action

The cetylated esters appear to calm inflammatory signaling within the joint, easing discomfort.

Clinical trials

1
Cetylated Fatty Acids and Knee Osteoarthritis — RCT
PubMed

Randomized controlled trial of cetylated fatty acids on knee function in osteoarthritis. (Hesslink et al. 2002, Journal of Rheumatology)

Adults with knee osteoarthritis.

Cetylated fatty acids improved knee function and range of motion versus placebo.

Side effects and drug interactions

Common Potential side effects

GENERALLY WELL-TOLERATED — adverse effects are uncommon at normal doses.
Mild digestive upset is occasionally reported.
Discontinue if any unusual reaction occurs.

Important Drug interactions

No major drug interactions are established for this ingredient.
Tell your doctor about all supplements if you take prescription medication.
Use caution if pregnant, breastfeeding, or managing a health condition.

Frequently asked questions about Estraflex® CMO (Cetylated Fatty Acids)

What is Estraflex® CMO (Cetylated Fatty Acids)?

Estraflex® CMO supplies cetylated fatty acids, a group of fats including cetyl myristoleate (CMO) studied for joint health. These specialized fatty acids appear to lubricate and calm the joints, and clinical research has examined them for improving comfort and function in osteoarthritis.

What is the recommended dosage of Estraflex® CMO (Cetylated Fatty Acids)?

The clinically studied dose for Estraflex® CMO (Cetylated Fatty Acids) is Commonly around 350 to 500 mg of cetylated fatty acids per day.. Always follow product labeling and consult a healthcare provider for personalized dosing recommendations.

What is Estraflex® CMO (Cetylated Fatty Acids) used for?

Estraflex® CMO (Cetylated Fatty Acids) is studied for joint function, joint comfort and mobility, joint lubrication. In a randomized controlled trial, cetylated fatty acids improved knee function in people with osteoarthritis, supporting their joint-comfort positioning.

Are there side effects from taking Estraflex® CMO (Cetylated Fatty Acids)?

Reported potential side effects may include: GENERALLY WELL-TOLERATED — adverse effects are uncommon at normal doses. Mild digestive upset is occasionally reported. Always consult a healthcare provider before starting any new supplement, especially if you have underlying conditions or take medications.

Is Estraflex® CMO (Cetylated Fatty Acids) safe to take?

Whether Estraflex® CMO (Cetylated Fatty Acids) is safe depends on the dose, your overall health, and any medications you take. At studied doses, reported side effects can include: GENERALLY WELL-TOLERATED — adverse effects are uncommon at normal doses. It may also interact with certain medications. Estraflex® CMO (Cetylated Fatty Acids) is not suitable for everyone — consult a healthcare provider before use if you are pregnant or breastfeeding, have a medical condition, or take prescription medications.

References(1 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Hesslink R Jr, Armstrong D 3rd, Nagendran MV, et al. Cetylated fatty acids improve knee function in patients with osteoarthritis. J Rheumatol. 2002;29(8):1708-12..PubMedUsed to support: RCT supporting joint-function benefit of cetylated fatty acids.